drug

differential diagnosis

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by IRCCS San Raffaele
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
A Biological Signature for the Early Differential Diagnosis of Psychosis
NCT06515522—Not Yet Recruiting

KOLs & investigators

1
Francesco Benedetti, Prof

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
IRCCS San Raffaele
company
trial
A Biological Signature for the Early Differential Diagnosis of Psychosis
trial
indication
Schizophrenia
indication
Bipolar Disorder
indication
Schizophrenia
indication
Depressive Disorder, Major
indication
KOL
Francesco Benedetti, Prof
KOL score —
person